<DOC>
	<DOCNO>NCT01141179</DOCNO>
	<brief_summary>The study investigate impact reduce renal function pharmacokinetic pharmacodynamic profile LEO 27847 . Volunteers different degree renal impairment administer one dose investigational drug follow investigational drug eliminate body .</brief_summary>
	<brief_title>The Impact Renal Impairment Pharmacokinetic Pharmacodynamic LEO 27847</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Main Male and/or nonchildbearing potential female , 18 year age old , healthy stable renal impairment ( deem stable refer physician least last 4 week expect change significantly next 3 month ) BMI ≥18.0 ≤ 42 kg/m2 Patients stable concomitant medical condition Healthy subject patient creatinine clearance ( time screen ) estimate use formula Cockcroft Gault within range : ≥ 50 ≤ 80 mL/min ( Mild Group : 8 subject ) , ≥ 30 &lt; 50 mL/min ( Moderate Group : 8 subject ) , &lt; 30 mL/min ( Severe Group : 8 subject ) . Main Patients renal transplant currently haemodialysis peritoneal dialysis Clinically significant illness surgery within 4 week prior dose Clinically significant ECG abnormality vital sign abnormality screen History stroke , cerebrovascular disorder , coronary angioplasty coronary bypass graft Clinically significant history presence gastrointestinal pathology Use medication stable medication within 14 day prior administration investigational product overthecounter product within 7 day prior administration investigational product , except : multivitamin vitamin D take regular basis topical product without systemic absorption Hemoglobin ≤ 90 g/L Serum total calcium ( adjust albumin ) level &lt; 2.25 mmol/L Clinically significant history congestive heart failure , cardiac dysfunction liver disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>